Septerna to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Company Overview - Septerna is a clinical-stage biotechnology company focused on GPCR-targeted drug discovery using its proprietary Native Complex Platform [3] - The company aims to unlock the full potential of GPCR therapies and has developed a pipeline of oral small molecule product candidates [3] - Initial therapeutic areas of focus include endocrinology, immunology and inflammation, and metabolic diseases [3] Upcoming Presentation - Jeffrey Finer, M.D., Ph.D., CEO and co-founder of Septerna, will present at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025, at 3:45 p.m. PT [1] - A live webcast of the presentation will be available on the company's website and archived for 30 days [2]